Our esteemed Gilead Board of Directors and Director Emeritus provide the leadership and guidance necessary to execute our mission and realize our vision.

Board of Directors

John C. Martin, PhD
Chairman and Chief Executive Officer, Gilead Sciences

James M. Denny
Lead Independent Director, Gilead Sciences Board of Directors

Paul Berg, PhD
Nobel Prize Winner, Chemistry
Cahill Professor, Emeritus, Stanford University

John F. Cogan, PhD
Senior Fellow, Hoover Institution, Stanford University

Etienne F. Davignon
Minister of State
Vice Chairman, Suez-Tractebel

Carla A. Hills
Chair and Chief Executive Officer, Hills & Company, International Consultants

Kevin E. Lofton
President and Chief Executive Officer, Catholic Health Initiatives

John W. Madigan
Retired Chairman and Chief Executive Officer, Tribune Company

Gordon E. Moore, PhD
Retired Chairman and Chief Executive Officer, Intel Corporation

Nicholas G. Moore
Retired Global Chairman, PricewaterhouseCoopers

Richard J. Whitley, MD
Distinguished Professor, Loeb Scholar Chair in Pediatrics, University of Alabama at Birmingham

Gayle Edlund Wilson
Chair, Ralph M. Parsons Foundation

Per Wold-Olsen
Retired President, Human Health Intercontinental Division, Merck & Co., Inc.

Director Emeritus

George P. Shultz, PhD
Distinguished Fellow, Hoover Institution, Stanford University